http://purl.org/np/RAEhbEJ1td... RAEhbEJ1td

links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance

http://www.w3.org/ns/prov#wasQuotedFrom wasQuotedFrom

Favipiravir was approved in Japan in 2014 to treat cases of influenza that were unresponsive to conventional treatment. It has been investigated in other countries to treat novel viruses including Ebola and most recently, COVID-19, which was recently approved in the U.S. for treatment of novel viruses such as Ebola and the Ebola virus. Given its efficacy at targetting several strains of influenza, it has been used in Japan to treat influenza patients.

Elif Ozkan

2022-10-13T13:56:25.822Z

http://purl.org/np/RAEhbEJ1td... RAEhbEJ1td

links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance

http://www.w3.org/ns/prov#wasAttributedTo wasAttributedTo

https://orcid.org/0000-0002-3668-2627 Elif Ozkan

Elif Ozkan

2022-10-13T13:56:25.822Z

http://purl.org/np/RAEhbEJ1td... RAEhbEJ1td

links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance

http://www.w3.org/ns/prov#generatedAtTime generatedAtTime

2022-10-13T13:56:25.822692

Elif Ozkan

2022-10-13T13:56:25.822Z